These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1796642)

  • 1. [Advanced heart failure: possible role of endothelin for renal failure; baroreceptor mechanism of vasopressin (AVP) stimulation in advanced heart failure and hyponatremia].
    Gross P; Ketteler M; Hensen J; Schömig A; Rascher W
    Z Kardiol; 1991; 80 Suppl 8():99-100. PubMed ID: 1796642
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent advances in the understanding of water metabolism in heart failure.
    Schrier RW; Martin PY
    Adv Exp Med Biol; 1998; 449():415-26. PubMed ID: 10026833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasopressin receptor antagonists: potential indications and clinical results.
    Arai Y; Fujimori A; Sudoh K; Sasamata M
    Curr Opin Pharmacol; 2007 Apr; 7(2):124-9. PubMed ID: 17292670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasopressin dysregulation: hyponatremia, fluid retention and congestive heart failure.
    LeJemtel TH; Serrano C
    Int J Cardiol; 2007 Aug; 120(1):1-9. PubMed ID: 17346825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyponatremia, arginine vasopressin dysregulation, and vasopressin receptor antagonism.
    Rai A; Whaley-Connell A; McFarlane S; Sowers JR
    Am J Nephrol; 2006; 26(6):579-89. PubMed ID: 17170524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasopressin dysregulation and hyponatremia in hospitalized patients.
    Multz AS
    J Intensive Care Med; 2007; 22(4):216-23. PubMed ID: 17712057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasopressin and vasopressin receptor antagonists in heart failure.
    Oghlakian G; Klapholz M
    Cardiol Rev; 2009; 17(1):10-5. PubMed ID: 19092365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurohumoral aspects of heart failure.
    Benedict CR
    Cardiol Clin; 1994 Feb; 12(1):9-23. PubMed ID: 7910114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of arginine vasopressin receptor antagonists in hyponatremia in the elderly.
    Miller M
    Geriatrics; 2007 Jul; 62(7):20-6. PubMed ID: 17620018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neurohormonal factors in heart failure. II].
    Cosín Aguilar J; Cruz Fernández JM; de Teresa Galván E; Ferreira Montero IJ; López-Sendón J; Soler Soler J; Tamargo Menéndez J
    Rev Esp Cardiol; 1996 May; 49(5):317-27. PubMed ID: 8744385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal adaptation to the failing heart. Understanding the cascade of responses.
    Riley DJ; Weir M; Bakris GL
    Postgrad Med; 1994 Jun; 95(8):141-6, 149-50. PubMed ID: 8202419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyponatremia in congestive heart failure.
    Oren RM
    Am J Cardiol; 2005 May; 95(9A):2B-7B. PubMed ID: 15847851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelin: a possible role in the occurrence of renal failure in thrombotic thrombocytopenic purpura.
    Spooren PF; Vermes I; Kip L; Haanen C
    Thromb Haemost; 1993 Apr; 69(4):401-32. PubMed ID: 8497855
    [No Abstract]   [Full Text] [Related]  

  • 14. Hyponatremia: pathophysiology, differential diagnosis and new aspects of treatment.
    Gross P; Wehrle R; Büssemaker E
    Clin Nephrol; 1996 Oct; 46(4):273-6. PubMed ID: 8905218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current treatments and novel pharmacologic treatments for hyponatremia in congestive heart failure.
    Goldsmith SR
    Am J Cardiol; 2005 May; 95(9A):14B-23B. PubMed ID: 15847853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin in renal disease: role of endothelin antagonists.
    Lüscher TF; Wenzel RR
    Nephrol Dial Transplant; 1995; 10(2):162-5. PubMed ID: 7753449
    [No Abstract]   [Full Text] [Related]  

  • 17. Baroreceptor function in congestive heart failure: effect on neurohumoral activation and regional vascular resistance.
    Hirsch AT; Dzau VJ; Creager MA
    Circulation; 1987 May; 75(5 Pt 2):IV36-48. PubMed ID: 2882866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurohormonal activation in congestive heart failure and the role of vasopressin.
    Chatterjee K
    Am J Cardiol; 2005 May; 95(9A):8B-13B. PubMed ID: 15847852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between kidney function, hemodynamic variables and circulating big endothelin levels in patients with severe refractory heart failure.
    Kos T; Pacher R; Wimmer A; Bojic A; Hülsmann M; Frey B; Mayer G; Yilmaz N; Skvarilova L; Spinar J; Vitovec J; Toman J; Woloszcuk W; Stanek B
    Wien Klin Wochenschr; 1998 Feb; 110(3):89-95. PubMed ID: 9553203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Water and sodium retention in edematous disorders: role of vasopressin and aldosterone.
    Schrier RW
    Am J Med; 2006 Jul; 119(7 Suppl 1):S47-53. PubMed ID: 16843085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.